The Center for Business Intelligence (CBI) Summit on Novel Drug Delivery Strategies will convene industry leaders in the drug delivery, business development, lifecycle management and the commercialization arena to discuss the growing drug delivery market. The conference will examine the effects of incorporating a novel drug delivery system into the product lifecycle in early stages of development by assessing markets prior to commercialization.
Novel drug delivery systems are brought to the market through strategic alliances between pharmaceutical, biotech and drug delivery companies. Licensing agreements are an integral part of that process and their complexity varies with the value of the technology and the stage of development it is introduced. On Day 1 of the conference, Foley & Lardner LLP Associate Michael Yamauchi will lead the session, “Analyzing Licensing Agreement Strategies through Interactive Mock Case Study Discussions.” This executive exchange facilitates open discussion on key issues surrounding strategic licensing agreements through the analysis of several mock case study problems. During this session, participants are separated into groups and presented with a case study problem. Attendees have the opportunity to participate directly in the discussion and strategize solutions with their peers. After a brief analysis, each group presents its case to the rest of the participants. Open exchange follows. Mock cases are designed around actual past licensing cases. Topics to be incorporated into the case studies include:
Let’s Talk Compliance | Provider Relief Fund: Reporting Requirements and Compliance Concerns